IPP Bureau
Need to strengthen food safety scientific standards: NITI Aayog
By IPP Bureau - July 24, 2023
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
Update on medical colleges in aspirational districts: PIB
By IPP Bureau - July 24, 2023
AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur
ABDM supports the integration of digital health infrastructure
By IPP Bureau - July 24, 2023
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
13.91 crore teleconsultations have been completed:PIB
By IPP Bureau - July 24, 2023
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
DGHS organizes National Webinar on National Organ and Tissue Transplant Organisation
By IPP Bureau - July 24, 2023
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
Apollo performs 23000+ multi-organ transplantation
By IPP Bureau - July 24, 2023
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
India brings traditional medicine at the forefront of India’s G20 presidency discourse: Amitabh Kant
By IPP Bureau - July 24, 2023
Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts
USFDA completes two cGMP inspections at Biocon Biologics' insulins facility in Malaysia
By IPP Bureau - July 24, 2023
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
Aurobindo Pharma gets 3 observations from USFDA for Unit 3 at Bachupally Village
By IPP Bureau - July 24, 2023
Aurobindo will respond to the US FDA within the stipulated timelines
Lupin receives tentative USFDA’s approval for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
By IPP Bureau - July 24, 2023
This product would be manufactured at Lupin's Nagpur facility in India
Lonza delivers 5.6% CER sales growth and 30% CORE EBITDA margin
By IPP Bureau - July 22, 2023
Good momentum in commercial CDMO business
Merck receives positive European Union CHMP opinion for Gefapixant
By IPP Bureau - July 22, 2023
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
Merck receives positive EU CHMP opinion for pembrolizumab plus Trastuzumab and Chemotherapy as first-line treatment for HER2-positive advanced gastric or gastroesophageal junction
By IPP Bureau - July 22, 2023
If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
Boehringer Ingelheim receives FDA approval for NexGard Plus
By IPP Bureau - July 22, 2023
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
